[ET Net News Agency, 19 May 2025] SIMCERE PHARMA (02096) rose 10.1% to HK$9.6.
It hits an intra-day high of HK$9.6, hitting a 52-week high, and an intra-day low of
HK$8.8. The total shares traded was 23.95 million, with a value of HK$223.4m. The active
buy/sell ratio is 65:35, with net buying turnover of HK$67.65m. CLSA LTD accounts for
greatest net responsive buying turnover of HK$9.67m, with volume weighted average price of
HK$9.299. CHINA INV INFO accounts for greatest net responsive selling turnover of
HK$16.61m, with volume weighted average price of HK$9.356. The stock has risen a combined
14.3% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 9.600 % Chg +10.09%
High 9.600 Low 8.800
Shares Tr 23.95m Turnover 223.4m
10-D SMA 8.695 %H.V 58.355
20-D SMA 8.600 VWAP 9.328
50-D SMA 8.194 RSI14 66.613
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 65:35, with net buying turnover
of HK$67.65m, rising a combined 14.3% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
SIMCERE PHARMA (02096) 9.60 +10.09
SIHUAN PHARM (00460) 0.77 +14.93
GRAND PHARMA (00512) 8.33 -1.19
SHANDONG XINHUA (00719) 6.13 -1.29
CMS (00867) 8.66 +5.10
CSPC PHARMA (01093) 5.96 +1.19
SINO BIOPHARM (01177) 4.09 +0.99
3SBIO (01530) 14.64 +14.91
WUXI APPTEC (02359) 63.00 -0.32
HANSOH PHARMA (03692) 23.60 +0.64
-----------------------------------------------
(ed)